MS 200 MG Extended Release Oral Tablet [MS Contin]

RxCUI: 892648
RxNorm name: MS 200 MG Extended Release Oral Tablet [MS Contin]
Display name: MS 200 MG Extended Release Oral Tablet [MS Contin]
Full name: MS 200 MG Extended Release Oral Tablet [MS Contin]
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:39:20

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
MS Contin	MORPHINE SULFATE	Rhodes Pharmaceuticals LLC	c354b3bf-86c0-4bb8-8b1f-be2164942698	2026-05-18	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 892648

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
c354b3bf-86c0-4bb8-8b1f-be2164942698	MS Contin 200 MG Extended Release Oral Tablet [PSN] · morphine sulfate 200 MG Extended Release Oral Tablet [MS Contin] [SBD] · MS 200 MG Extended Release Oral Tablet [MS Contin] [SY] · MS Contin 200 MG Extended Release Oral Tablet [SY]	4	16	These highlights do not include all the information needed to use MS CONTIN ® safely and effectively. See full prescribing information for MS CONTIN. MS CONTIN ® (morphine sulfate extended-release tablets), for oral use CII Initial U.S. Approval: 1941	20260504